Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Rådegran G[au]:

Search results

Items: 1 to 50 of 100

1.

Sex-specific differences and survival in patients with idiopathic pulmonary arterial hypertension 2008-2016.

Kjellström B, Nisell M, Kylhammar D, Bartfay SE, Ivarsson B, Rådegran G, Hjalmarsson C.

ERJ Open Res. 2019 Aug 12;5(3). pii: 00075-2019. doi: 10.1183/23120541.00075-2019. eCollection 2019 Jul.

2.

[Patients' perspective of living with PAH or CTEPH in Sweden].

Ivarsson B, Hesselstrand R, Rådegran G, Kjellström B.

Lakartidningen. 2019 May 1;116. pii: FITF. Swedish.

3.

[Pulmonary hypertension due to left heart disease - not to be confused with pulmonary arterial hypertension].

Lundgren J, Rådegran G.

Lakartidningen. 2019 Mar 26;116. pii: FI6I. Swedish.

4.

Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study.

Gustafsson F, Andreassen AK, Andersson B, Eiskjær H, Rådegran G, Gude E, Jansson K, Solbu D, Karason K, Arora S, Dellgren G, Gullestad L; SCHEDULE (Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance) investigators.

Transplantation. 2019 Mar 12. doi: 10.1097/TP.0000000000002702. [Epub ahead of print]

PMID:
30893292
5.

Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Ivarsson B, Sjöberg T, Hesselstrand R, Rådegran G, Kjellström B.

ERJ Open Res. 2019 Feb 25;5(1). pii: 00218-2018. doi: 10.1183/23120541.00218-2018. eCollection 2019 Feb.

6.

Impact of gender on echocardiographic characteristics in heart transplant recipients.

Ingvarsson A, Werther-Evaldsson A, Smith GJ, Waktare J, Nilsson J, Stagmo M, Roijer A, Rådegran G, Meurling C.

Clin Physiol Funct Imaging. 2019 Jul;39(4):246-254. doi: 10.1111/cpf.12565. Epub 2019 Mar 6.

PMID:
30770630
7.

Behandlingen av patienter med svår hjärtsvikt kan förbättras - Eftersatt tillstånd som fortfarande underbehandlas.

Bjurman C, Holzmann M, Juhlin T, Rådegran G.

Lakartidningen. 2018 Dec 28;115. pii: FDX6. Review. Swedish. No abstract available.

8.

Bone mineral density and osteoporosis in heart transplanted patients: A single-center retrospective study at Skåne University Hospital in Lund 1988-2016.

Löfdahl E, Söderlund C, Rådegran G.

Clin Transplant. 2019 Mar;33(3):e13477. doi: 10.1111/ctr.13477. Epub 2019 Jan 30.

PMID:
30618200
9.

Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.

Lindholm A, Hesselstrand R, Rådegran G, Arheden H, Ostenfeld E.

Clin Physiol Funct Imaging. 2019 May;39(3):215-225. doi: 10.1111/cpf.12561. Epub 2019 Jan 16.

PMID:
30597705
10.

Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertension.

Bouzina H, Rådegran G.

ERJ Open Res. 2018 Nov 12;4(4). pii: 00035-2018. doi: 10.1183/23120541.00035-2018. eCollection 2018 Oct.

11.

Pulmonary arterial hypertension: assessing risk to improve prognosis.

Kjellström B, Hjalmarsson C, Kylhammar D, Rådegran G.

Expert Rev Cardiovasc Ther. 2019 Jan;17(1):1-2. doi: 10.1080/14779072.2019.1548278. Epub 2018 Nov 15. No abstract available.

PMID:
30422719
12.

Echocardiographic right ventricular strain from multiple apical views is superior for assessment of right ventricular systolic function.

Werther Evaldsson A, Ingvarsson A, Smith JG, Rådegran G, Roijer A, Waktare J, Ostenfeld E, Meurling C.

Clin Physiol Funct Imaging. 2019 Mar;39(2):168-176. doi: 10.1111/cpf.12552. Epub 2018 Oct 30.

PMID:
30375714
13.

Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients.

Arora S, Andreassen AK, Karason K, Gustafsson F, Eiskjær H, Bøtker HE, Rådegran G, Gude E, Ioanes D, Solbu D, Dellgren G, Ueland T, Aukrust P, Gullestad L; SCHEDULE (Scandinavian Heart Transplant Everolimus De Novo Study With Early Calcineurin Inhibitors Avoidance) Investigators.

Circ Heart Fail. 2018 Sep;11(9):e004050. doi: 10.1161/CIRCHEARTFAILURE.117.004050.

PMID:
30354362
14.
15.

Diagnosing and grading heart failure with tomographic perfusion lung scintigraphy: validation with right heart catheterization.

Jögi J, Al-Mashat M, Rådegran G, Bajc M, Arheden H.

ESC Heart Fail. 2018 Oct;5(5):902-910. doi: 10.1002/ehf2.12317. Epub 2018 Jul 17.

16.

Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Ivarsson B, Hesselstrand R, Rådegran G, Kjellström B.

Chron Respir Dis. 2019 Jan-Dec;16:1479972318787906. doi: 10.1177/1479972318787906. Epub 2018 Jul 16.

17.

Increased right atrial volume measured with cardiac magnetic resonance is associated with worse clinical outcome in patients with pre-capillary pulmonary hypertension.

Bredfelt A, Rådegran G, Hesselstrand R, Arheden H, Ostenfeld E.

ESC Heart Fail. 2018 Oct;5(5):864-875. doi: 10.1002/ehf2.12304. Epub 2018 Jun 19.

18.

[50 years of heart transplantations].

Söderlund C, Rådegran G.

Lakartidningen. 2018 Apr 12;115. pii: E4ZH. Swedish.

19.

Alterations in plasma L-arginine and methylarginines in heart failure and after heart transplantation.

Lundgren J, Sandqvist A, Hedeland M, Bondesson U, Wikström G, Rådegran G.

Scand Cardiovasc J. 2018 Aug;52(4):196-204. doi: 10.1080/14017431.2018.1459823. Epub 2018 Apr 12.

PMID:
29648475
20.

Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension.

Hjalmarsson C, Rådegran G, Kylhammar D, Rundqvist B, Multing J, Nisell MD, Kjellström B; SveFPH and SPAHR.

Eur Respir J. 2018 May 3;51(5). pii: 1702310. doi: 10.1183/13993003.02310-2017. Print 2018 May.

PMID:
29622568
21.

Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension.

Kylhammar D, Hesselstrand R, Nielsen S, Scheele C, Rådegran G.

Scand J Rheumatol. 2018 Jul;47(4):319-324. doi: 10.1080/03009742.2017.1378714. Epub 2018 Mar 12.

PMID:
29528272
22.

Adherence and medication belief in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A nationwide population-based cohort survey.

Ivarsson B, Hesselstrand R, Rådegran G, Kjellström B.

Clin Respir J. 2018 Jun;12(6):2029-2035. doi: 10.1111/crj.12770. Epub 2018 Feb 5.

PMID:
29356440
23.

Coping, social support and information in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A 2-year retrospective cohort study.

Ivarsson B, Rådegran G, Hesselstrand R, Kjellström B.

SAGE Open Med. 2018 Jan 4;6:2050312117749159. doi: 10.1177/2050312117749159. eCollection 2018.

24.

[Pulmonary hypertension – a common condition in left heart disease].

Lundgren J, Rådegran G.

Lakartidningen. 2017 Dec 1;114. pii: ER3E. Review. Swedish.

25.

Normal Reference Ranges for Transthoracic Echocardiography Following Heart Transplantation.

Ingvarsson A, Werther Evaldsson A, Waktare J, Nilsson J, Smith GJ, Stagmo M, Roijer A, Rådegran G, Meurling CJ.

J Am Soc Echocardiogr. 2018 Mar;31(3):349-360. doi: 10.1016/j.echo.2017.11.003. Epub 2017 Dec 21.

PMID:
29275986
26.

Right ventricular speckle tracking assessment for differentiation of pressure- versus volume-overloaded right ventricle.

Werther Evaldsson A, Ingvarsson A, Waktare J, Smith GJ, Thilén U, Stagmo M, Roijer A, Rådegran G, Meurling C.

Clin Physiol Funct Imaging. 2018 Sep;38(5):763-771. doi: 10.1111/cpf.12477. Epub 2017 Oct 26.

PMID:
29076284
27.

Plasma L-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction.

Sandqvist A, Schneede J, Kylhammar D, Henrohn D, Lundgren J, Hedeland M, Bondesson U, Rådegran G, Wikström G.

Heart Vessels. 2018 Mar;33(3):255-263. doi: 10.1007/s00380-017-1055-7. Epub 2017 Oct 3.

28.

Osteoporosis following heart transplantation and immunosuppressive therapy.

Löfdahl E, Rådegran G.

Transplant Rev (Orlando). 2017 Oct;31(4):232-239. doi: 10.1016/j.trre.2017.08.002. Epub 2017 Aug 12. Review.

PMID:
28865930
29.

Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension.

Säleby J, Bouzina H, Lundgren J, Rådegran G.

Scand Cardiovasc J. 2017 Oct;51(5):261-270. doi: 10.1080/14017431.2017.1359419. Epub 2017 Aug 4.

PMID:
28776404
30.

[Pulmonary hypertension due to lung diseases].

Kylhammar D, Rådegran G.

Lakartidningen. 2017 Jul 21;114. pii: ELAL. Review. Swedish.

31.

Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE).

Relbo Authen A, Grov I, Karason K, Gustafsson F, Eiskjaer H, Rådegran G, Gude E, Jansson K, Dellgren G, Solbu D, Arora S, Andreassen AK, Gullestad L.

Clin Transplant. 2017 Sep;31(9). doi: 10.1111/ctr.13038. Epub 2017 Jul 19.

PMID:
28640529
32.

A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.

Kylhammar D, Kjellström B, Hjalmarsson C, Jansson K, Nisell M, Söderberg S, Wikström G, Rådegran G.

Eur Heart J. 2018 Dec 14;39(47):4175-4181. doi: 10.1093/eurheartj/ehx257.

PMID:
28575277
33.

Acute cellular rejection later than one year after heart transplantation: A single-center retrospective study at Skåne University Hospital in Lund 1988-2010.

Söderlund C, Rådegran G.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12998. Epub 2017 May 29.

PMID:
28480572
34.

Impact of postoperative pulmonary hypertension on outcome after heart transplantation.

Lundgren J, Söderlund C, Rådegran G.

Scand Cardiovasc J. 2017 Jun;51(3):172-181. doi: 10.1080/14017431.2017.1304569. Epub 2017 Mar 22.

PMID:
28326855
35.

Effect of Calcineurin Inhibitor-Free, Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate After Heart Transplantation.

Nelson LM, Andreassen AK, Andersson B, Gude E, Eiskjær H, Rådegran G, Dellgren G, Gullestad L, Gustafsson F.

Transplantation. 2017 Nov;101(11):2793-2800. doi: 10.1097/TP.0000000000001706.

PMID:
28230646
36.

Information, social support and coping in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension-A nationwide population-based study.

Ivarsson B, Rådegran G, Hesselstrand R, Kjellström B.

Patient Educ Couns. 2017 May;100(5):936-942. doi: 10.1016/j.pec.2016.12.021. Epub 2016 Dec 21.

PMID:
28041647
37.

Discriminatory ability of right atrial volumes with two- and three-dimensional echocardiography to detect elevated right atrial pressure in pulmonary hypertension.

Ostenfeld E, Werther-Evaldsson A, Engblom H, Ingvarsson A, Roijer A, Meurling C, Holm J, Rådegran G, Carlsson M.

Clin Physiol Funct Imaging. 2018 Mar;38(2):192-199. doi: 10.1111/cpf.12398. Epub 2016 Dec 7.

PMID:
27925364
38.

The principal pathways involved in the in vivo modulation of hypoxic pulmonary vasoconstriction, pulmonary arterial remodelling and pulmonary hypertension.

Kylhammar D, Rådegran G.

Acta Physiol (Oxf). 2017 Apr;219(4):728-756. doi: 10.1111/apha.12749. Epub 2016 Jul 31. Review.

PMID:
27381367
39.

Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.

Rådegran G, Kjellström B, Ekmehag B, Larsen F, Rundqvist B, Blomquist SB, Gustafsson C, Hesselstrand R, Karlsson M, Kornhall B, Nisell M, Persson L, Ryftenius H, Selin M, Ullman B, Wall K, Wikström G, Willehadson M, Jansson K; Stefan Söderberg j , on behalf of SveFPH and SPAHR.

Scand Cardiovasc J. 2016 Aug;50(4):243-50. doi: 10.1080/14017431.2016.1185532. Epub 2016 Jun 14.

PMID:
27146648
40.

Regional contribution to ventricular stroke volume is affected on the left side, but not on the right in patients with pulmonary hypertension.

Ostenfeld E, Stephensen SS, Steding-Ehrenborg K, Heiberg E, Arheden H, Rådegran G, Holm J, Carlsson M.

Int J Cardiovasc Imaging. 2016 Aug;32(8):1243-53. doi: 10.1007/s10554-016-0898-9. Epub 2016 May 3.

PMID:
27142431
41.

Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial.

Gullestad L, Eiskjaer H, Gustafsson F, Riise GC, Karason K, Dellgren G, Rådegran G, Hansson L, Gude E, Bjørtuft Ø, Jansson K, Schultz HH, Solbu D, Iversen M.

Transpl Int. 2016 Jul;29(7):819-29. doi: 10.1111/tri.12783. Epub 2016 May 30.

42.

Wound complications and surgical events in de novo heart transplant patients treated with everolimus: Post-hoc analysis of the SCHEDULE trial.

Rashidi M, Esmaily S, Fiane AE, Gude E, A Tønseth K, Ueland T, Gustafsson F, Eiskjær H, Rådegran G, Dellgren G.

Int J Cardiol. 2016 May 1;210:80-4. doi: 10.1016/j.ijcard.2016.02.075. Epub 2016 Feb 9.

PMID:
26938682
43.

Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study.

Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Rådegran G, Gude E, Jansson K, Solbu D, Karason K, Arora S, Dellgren G, Gullestad L; SCHEDULE investigators.

Am J Transplant. 2016 Apr;16(4):1238-47. doi: 10.1111/ajt.13588. Epub 2016 Jan 28.

44.

[Pulmonary arterial hypertension--severe prognosis despite major progress].

Jansson K, Kjellström B, Söderberg S, Larsen F, Rådegran G.

Lakartidningen. 2015 Oct 27;112. pii: DLPA. Swedish. No abstract available.

45.

Chronic kidney disease after heart transplantation: a single-centre retrospective study at Skåne University Hospital in Lund 1988-2010.

Söderlund C, Löfdahl E, Nilsson J, Reitan Ö, Higgins T, Rådegran G.

Transpl Int. 2016 May;29(5):529-39. doi: 10.1111/tri.12710.

46.

Mechanical compression during repeated sustained isometric muscle contractions and hyperemic recovery in healthy young males.

Osada T, Mortensen SP, Rådegran G.

J Physiol Anthropol. 2015 Oct 31;34:36. doi: 10.1186/s40101-015-0075-1.

47.

A new equation to estimate temperature-corrected PaCO2 from PET CO2 during exercise in normoxia and hypoxia.

González Henríquez JJ, Losa-Reyna J, Torres-Peralta R, Rådegran G, Koskolou M, Calbet JA.

Scand J Med Sci Sports. 2016 Sep;26(9):1045-51. doi: 10.1111/sms.12545. Epub 2015 Aug 27.

PMID:
26314285
48.

Hemodynamic Characteristics Including Pulmonary Hypertension at Rest and During Exercise Before and After Heart Transplantation.

Lundgren J, Rådegran G.

J Am Heart Assoc. 2015 Jul 21;4(7). pii: e001787. doi: 10.1161/JAHA.115.001787.

49.

Safety and efficacy of the switch to generic mycophenolate mofetil and tacrolimus in heart transplant patients.

Söderlund C, Rådegran G.

Clin Transplant. 2015 Jul;29(7):619-28. doi: 10.1111/ctr.12564. Epub 2015 Jun 16.

PMID:
25981927
50.

Immunosuppressive therapies after heart transplantation--The balance between under- and over-immunosuppression.

Söderlund C, Rådegran G.

Transplant Rev (Orlando). 2015 Jul;29(3):181-9. doi: 10.1016/j.trre.2015.02.005. Epub 2015 Feb 28. Review.

PMID:
25812489

Supplemental Content

Loading ...
Support Center